285 related articles for article (PubMed ID: 25809273)
1. Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells.
Gregory KJ; Schneider SS
Cell Biol Int; 2015 Jul; 39(7):873-9. PubMed ID: 25809273
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
3. Loss of SFRP1 promotes ductal branching in the murine mammary gland.
Gauger KJ; Shimono A; Crisi GM; Schneider SS
BMC Dev Biol; 2012 Aug; 12():25. PubMed ID: 22928951
[TBL] [Abstract][Full Text] [Related]
4. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
5. SFRP1 reduction results in an increased sensitivity to TGF-β signaling.
Gauger KJ; Chenausky KL; Murray ME; Schneider SS
BMC Cancer; 2011 Feb; 11():59. PubMed ID: 21303533
[TBL] [Abstract][Full Text] [Related]
6. The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.
Gauger KJ; Bassa LM; Henchey EM; Wyman J; Ser-Dolansky J; Shimono A; Schneider SS
Mol Cancer; 2014 May; 13():117. PubMed ID: 24885183
[TBL] [Abstract][Full Text] [Related]
7. Regulation of early growth response 2 expression by secreted frizzled related protein 1.
Gregory KJ; Morin SM; Schneider SS
BMC Cancer; 2017 Jul; 17(1):473. PubMed ID: 28687085
[TBL] [Abstract][Full Text] [Related]
8. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature of atypical breast hyperplasia and regulation by SFRP1.
Gregory KJ; Roberts AL; Conlon EM; Mayfield JA; Hagen MJ; Crisi GM; Bentley BA; Kane JJ; Makari-Judson G; Mason HS; Yu J; Zhu LJ; Simin K; Johnson JPS; Khan A; Schneider BR; Schneider SS; Jerry DJ
Breast Cancer Res; 2019 Jun; 21(1):76. PubMed ID: 31248446
[TBL] [Abstract][Full Text] [Related]
10. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
11. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer.
Shulewitz M; Soloviev I; Wu T; Koeppen H; Polakis P; Sakanaka C
Oncogene; 2006 Jul; 25(31):4361-9. PubMed ID: 16532032
[TBL] [Abstract][Full Text] [Related]
12. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
13. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
[TBL] [Abstract][Full Text] [Related]
15. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
16. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.
Klopocki E; Kristiansen G; Wild PJ; Klaman I; Castanos-Velez E; Singer G; Stöhr R; Simon R; Sauter G; Leibiger H; Essers L; Weber B; Hermann K; Rosenthal A; Hartmann A; Dahl E
Int J Oncol; 2004 Sep; 25(3):641-9. PubMed ID: 15289865
[TBL] [Abstract][Full Text] [Related]
17. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
